Location History:
- Leicestershire, GB (2007)
- Loughborough, GB (2011)
Company Filing History:
Years Active: 2007-2011
Title: Adam Herring: Innovator in Cardiac Arrhythmia Treatments
Introduction
Adam Herring is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac arrhythmias. With a total of 2 patents to his name, Herring's work is recognized for its potential impact on cardiac health.
Latest Patents
Herring's latest patents include innovative compounds aimed at treating cardiac arrhythmias. The first patent, titled "Oxabispidine compounds for the treatment of cardiac arrhythmias," provides compounds of formula I, wherein R, R, R, R to R, X, Y, and Z have meanings given in the description. These compounds are useful in the prophylaxis and treatment of arrhythmias, particularly atrial and ventricular arrhythmias. The second patent, "3,7-Diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds," describes substantially crystalline forms of various compounds that are also effective in treating cardiac arrhythmias.
Career Highlights
Adam Herring is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on developing innovative treatments that address critical health issues, particularly in cardiology.
Collaborations
Herring collaborates with talented professionals in his field, including Annika Björe and David Cladingboel. These collaborations enhance the research and development of effective treatments for cardiac conditions.
Conclusion
Adam Herring's contributions to the field of cardiac arrhythmia treatments through his patents and work at AstraZeneca AB highlight his commitment to improving patient outcomes. His innovative approaches continue to pave the way for advancements in cardiac health.